Member Info for Soupdragon78

Good point older, I'll ask, although I think he blew his allowance on his snazzy big office chair. (he wanted one that spins as Vectura wouldn't let him have the spinny chair so he left.)

fre1, its mostly those who bought over the past few days and have been vocal now selling out. It happens often here.

Indeed kane, those who were trading it earlier in the year whilst trying to tell everyone news was ‘incoming’ or the ‘lost data’ had been found have been very quiet lately.

Soupy twist m'colleague.

Earl, just go to Moderna's website, they actually tell you what their 'innovative' technique is.

Its nothing to do with Nuformix.

Market reacting to Moderna's vaccine now showing 95% effective.

lol, glad to see lse filters his handle out.

All very quiet on here, I guess only twitters ************ is excited enough to talk about 1 codes and premiums being paid on 100 quid trades, despite it actually being a UT.

You must have a short memory as I remember him doing 14 interviews through 2019 into 2020.

Yuyu’s, I have no clear answer as to what’s going on, as like everyone else here, I do not have any knowledge that’s not in the public realm.

As for whether I ‘envisage something good soon’, I would like to think something good is coming as I have a substantial investment here. If I didn’t think so then I wouldn’t be here.
When it will come and what it will pertain is purely guesswork.
What I would like to see, if there is no NXP002 out licensing in the short term, is for the company to develop its existing business and bolster the sp on that side, proving they can deliver.

Got to love the twitterati, the same people who last week were saying NFX was not a covid stock are now saying it is a covid stock this week.

They flip-flop more than BoJo when he shows up for work.

I think that the IPF and ARDS treatment offered by NXP002 is way more valuable to NFX than the cytokine storm suppression.

Well that was fun while it lasted, managed to go back down when nobody was posting so I guess the big seller doesn't agree with the de-ramping theories.

Earl, are you saying NXP002 is based on Turmeric and not Tranilast?

Earl, with respect that interview is from July, people want to know whats happening now its November.

Yuyu's if you are willing to dismiss a contract worth up to £51m for a company with mcp of £15m then I guess thats your prerogative.
As FX says, if they can't action the smaller deals what confidence does that give to a bigger player? Especially as they said they would update on the Vistagen deal before now.

No mention of anything in Vistagens latest reporting. It lists all the other collaborations and AV-101 developments over the past period, but not NFX.

Peace and love to SharesRus on twitter, he doesn’t look at LSE bb, but he set up his twitter account purely to tell everyone that nfx is about to take off everyday for the past few months.

Wonder how he managed to hear about the company then, almost as if it’s someone’s alter ego.

Shurely shome mishtake?

Have to say I enjoy reading SharesRus on twitter, apparently 'news will drop when its least expected' here, even though everyone is expecting news.

Difficult to say storm, given that the placing money was for specific tasks, so you would expect.

Ball park figures, NFX typically goes through over £1.1m per year. So knock £150k off for DG leaving. Say, £950k or £80k per month.
They had £540k in bank at end of March, so after 6 months would have used £480k of that.
Placing was then £650k + the £70k remaining gives £720k to play with, or another 9 months, depending on what they do with it.
A couple of nominal payments received as well but not counting them as we don't know what they are.